Medley Therapeutics, Inc.
PrivateLast Round
Series B
Jan 12, 2022
Total Funding Raised
$30.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Medley Therapeutics, Inc. is a biotechnology company that develops regenerative genetic medicines and advanced biologics to treat severe diseases such as heart failure, fibrotic diseases, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medley Therapeutics, Inc. Comparables
Compare Medley Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivace Therapeutics | 86% | |
| Renova Therapeutics | 84% | |
| Tenaya Therapeutics | 81% |
Medley Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2022 | ||||
| Seed | Mar 1, 2021 |
Medley Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fjord Ventures | Series B |
| ArrowMark Partners | Series B |
| Alexandria Venture Investments | Seed |
| BCM Ventures | Series B |
| Alexandria Venture Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2026
Grew 43% QoQ, from 7 to 10 employees.
- Jan 12, 2022
$30M round with participation from ArrowMark Partners and Fjord Ventures.
Medley Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medley Therapeutics, Inc.'s valuation, stock price, and market status.
Is Medley Therapeutics, Inc. a public or private company?
Medley Therapeutics, Inc. is a private company.
What is the current stock price of Medley Therapeutics, Inc.?
Medley Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Medley Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medley Therapeutics, Inc. worth (valuation)?
Valuation information for Medley Therapeutics, Inc. is not publicly available.
Can I buy Medley Therapeutics, Inc. stock?
Medley Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medley Therapeutics, Inc.'s last funding round?
Medley Therapeutics, Inc.'s most recent funding round was Series B on January 12, 2022.
Who are the main investors in Medley Therapeutics, Inc.?
Key investors in Medley Therapeutics, Inc. include Fjord Ventures, ArrowMark Partners, Alexandria Venture Investments, BCM Ventures, Alexandria Venture Investments.
Will Medley Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Medley Therapeutics, Inc..
How can I track Medley Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Medley Therapeutics, Inc.'s shares on secondary markets.